27841837|t|Bilateral Sensory Changes and High Burden of Disease in Patients with Chronic Pain and Unilateral Nondermatomal Somatosensory Deficits: A Quantitative Sensory Testing and Clinical Study
27841837|a|Widespread sensory deficits resembling hemihypoaesthesia occur in 20-40% of chronic pain patients on the side of pain, independent of pain aetiology, and have been termed nondermatomal sensory deficits (NDSD). Sensory profiles have rarely been investigated in NDSD. Quantitative sensory testing (QST) according to the protocol of the German Research Network on Neuropathic Pain (DFNS) was performed in the face, hand and foot of the painful body side and in contralateral regions in chronic pain patients. Twenty-five patients with NDSD and 23 without NDSD (termed pain-only group) were included after exclusion of neuropathic pain. Comprehensive clinical and psychiatric evaluations were done. NDSD in chronic pain was associated with high burden of disease and more widespread pain. Only in the NDSD group significantly higher thresholds for mechanical and painful stimuli were found in at least 2 of 3 regions ipsilateral to pain. In addition, we found a bilateral loss of function for temperature and vibration detection, and a gain of function for pressure pain in certain regions in patients with NDSD. Sensory loss and gain of function for pressure pain correlated with pain intensity in several regions. This may indicate a distinct sensory profile in chronic non - neuropathic pain and NDSD, probably attributable to altered central pain processing and sensitisation. The presence of NDSD in chronic non - neuropathic pain may be regarded as a marker for higher burden of pain disease.
27841837	0	9	Bilateral	T082	C0238767
27841837	10	25	Sensory Changes	T184	C1409715
27841837	45	52	Disease	T047	C0012634
27841837	56	64	Patients	T101	C0030705
27841837	70	82	Chronic Pain	T184	C0150055
27841837	87	97	Unilateral	T082	C0205092
27841837	98	134	Nondermatomal Somatosensory Deficits	T047	C0752262
27841837	138	166	Quantitative Sensory Testing	T060	C0430838
27841837	171	185	Clinical Study	T062	C0008972
27841837	197	213	sensory deficits	T047	C0748618
27841837	225	242	hemihypoaesthesia	T033	C4049566
27841837	262	274	chronic pain	T184	C0150055
27841837	275	283	patients	T101	C0030705
27841837	291	303	side of pain	T184	C0748706
27841837	320	324	pain	T184	C0030193
27841837	325	334	aetiology	T169	C1314792
27841837	357	387	nondermatomal sensory deficits	T047	C0748618
27841837	389	393	NDSD	T047	C0748618
27841837	396	412	Sensory profiles	T170	C2732625
27841837	446	450	NDSD	T047	C0748618
27841837	452	480	Quantitative sensory testing	T060	C0430838
27841837	482	485	QST	T060	C0430838
27841837	504	512	protocol	T061	C0008971
27841837	520	563	German Research Network on Neuropathic Pain	T093	C1708333
27841837	565	569	DFNS	T093	C1708333
27841837	592	596	face	T029	C0015450
27841837	598	602	hand	T023	C0018563
27841837	607	611	foot	T023	C0016504
27841837	619	636	painful body side	T184	C0748706
27841837	644	665	contralateral regions	T082	C0441988
27841837	669	681	chronic pain	T184	C0150055
27841837	682	690	patients	T101	C0030705
27841837	704	712	patients	T101	C0030705
27841837	718	722	NDSD	T047	C0748618
27841837	738	742	NDSD	T047	C0748618
27841837	801	817	neuropathic pain	T033	C3714625
27841837	833	841	clinical	T058	C4084924
27841837	846	869	psychiatric evaluations	T060	C0846574
27841837	881	885	NDSD	T047	C0748618
27841837	889	901	chronic pain	T184	C0150055
27841837	937	944	disease	T047	C0012634
27841837	965	969	pain	T184	C0030193
27841837	983	987	NDSD	T047	C0748618
27841837	1015	1025	thresholds	T080	C0449864
27841837	1030	1040	mechanical	T042	C1327503
27841837	1045	1052	painful	T184	C0030193
27841837	1053	1060	stimuli	T067	C0234402
27841837	1091	1098	regions	T029	C0005898
27841837	1099	1110	ipsilateral	T082	C0441989
27841837	1114	1118	pain	T184	C0030193
27841837	1144	1153	bilateral	T082	C0238767
27841837	1154	1170	loss of function	T033	C4061179
27841837	1175	1186	temperature	T032	C0005903
27841837	1191	1210	vibration detection	T042	C0036658
27841837	1226	1234	function	T169	C0542341
27841837	1239	1252	pressure pain	T184	C3647129
27841837	1264	1271	regions	T029	C0005898
27841837	1275	1283	patients	T101	C0030705
27841837	1289	1293	NDSD	T047	C0748618
27841837	1295	1307	Sensory loss	T184	C0278134
27841837	1333	1346	pressure pain	T184	C3647129
27841837	1363	1377	pain intensity	T201	C1320357
27841837	1389	1396	regions	T029	C0005898
27841837	1427	1442	sensory profile	T170	C2732625
27841837	1446	1453	chronic	T079	C0205191
27841837	1454	1457	non	T033	C1513916
27841837	1460	1476	neuropathic pain	T033	C3714625
27841837	1481	1485	NDSD	T047	C0748618
27841837	1520	1532	central pain	T184	C0234243
27841837	1548	1561	sensitisation	T047	C3839736
27841837	1579	1583	NDSD	T047	C0748618
27841837	1587	1594	chronic	T079	C0205191
27841837	1595	1598	non	T033	C1513916
27841837	1601	1617	neuropathic pain	T033	C3714625
27841837	1639	1645	marker	T201	C0005516
27841837	1667	1679	pain disease	T047	C0012634